Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
01/2001
01/17/2001EP1069188A1 Three neprilysin-like membrane metallopeptidases
01/17/2001EP1069186A1 Gene encoding desulfurases
01/17/2001EP1069183A2 Immobilized lipase
01/17/2001EP1068362A1 Hepatitis c virus ns5b compositions and methods of use thereof
01/17/2001EP1068342A2 MODIFICATION OF FATTY ACID COMPOSITION IN PLANTS BY EXPRESSION OF AN $i(ASPERGILLUS NIDULANS) DELTA-9 COA DESATURASE
01/17/2001EP1068338A2 Enhanced prodrug activation
01/17/2001EP1068336A2 Membranemetalloprotease nepii
01/17/2001EP1068335A2 Cell cycle regulatory proteins
01/17/2001EP1068334A2 Cell cycle regulatory proteins cdc-16, dp-1, dp-2 and e2f from plants
01/17/2001EP1068333A1 Starch r1 phosphorylation protein homologs
01/17/2001EP1068332A2 Recombinant anti-tumor rnase
01/17/2001EP1068331A1 Medicaments for inducing cytotoxic t-cells
01/17/2001EP1068330A2 Recombinant potyvirus construct and use thereof
01/17/2001EP1068324A2 Plant 1,3-beta-d-glucan synthase and brittle-1 encoding sequences
01/17/2001EP1068315A2 Therapeutic agent for ngf
01/17/2001EP1068305A2 High throughput dna sequencing vector
01/17/2001EP1068304A1 Treatment of parasitic diseases by inhibition of cysteine proteases of the papain superfamily
01/17/2001EP1068303A2 Assay for the diagnosis of schizophrenia based on a new peptide
01/17/2001EP1068302A2 Non-maltogenic exoamylases and their use in retarding retrogradation of starch
01/17/2001EP1068301A2 Bacterial transglutaminases
01/17/2001EP1068296A1 Methods and compositions for eliciting an immune response to a telomerase antigen
01/17/2001EP1068294A1 Microbial strains and processes for the manufacture of biomaterials
01/17/2001EP1068232A2 Human antibiotic proteins
01/17/2001EP1068228A1 Protease conjugates
01/17/2001EP1068220A1 nrdF
01/17/2001EP1067961A2 Leishmania cysteine proteinases
01/17/2001EP1067953A1 Methods for treating an ischemic disorder and improving stroke outcome
01/17/2001EP1067949A1 Sequence and method for genetic engineering of proteins with cell membrane translocating activity
01/17/2001EP1067917A2 Method of treating dopaminergic and gaba-nergic disorders
01/17/2001EP1067912A1 Modified starch coating
01/17/2001EP1067893A2 Human galactosyl transferases
01/17/2001EP0804532B1 Coated enzyme granules
01/17/2001EP0788555B1 Methods of analysis and manipulation of dna utilizing mismatch repair systems
01/17/2001EP0490919B1 Cytoprotective compounds bearing unsaturated hydrocarbon groups having 16 to 20 carbon atoms
01/17/2001CN1280627A Proteinase inhibitor fusion proteins
01/17/2001CN1280626A Pre-and posharvest inhibition of remobilisation of storage compounds
01/17/2001CN1280625A Nuclear male sterile plants, method of producing same and method to restore fertility
01/17/2001CN1280624A Nucleic and molecules which encode proteins having fructosyl transterase activity and methods for producing long-chain inulin
01/17/2001CN1280623A Method and compositions useful for activation of silent transgenes
01/17/2001CN1280622A Modification of the tocopherol content of transgenic plants
01/17/2001CN1280621A Alkaline protease
01/17/2001CN1280614A Recombinational cloning using nucleic acids having recombinatin sites
01/17/2001CN1280613A Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor
01/17/2001CN1280189A 固定化脂酶 Immobilized lipase
01/17/2001CN1280186A New type low temperature akaline protease and its producing method and use and microbe for producing said protease
01/17/2001CN1280135A Method for producing L-leucine and related DNA and microorganism
01/17/2001CN1279893A Artificial milk similar to human milk
01/17/2001CN1060807C Method for producing plasmid of expression external gene and ox prorennin in colonbacillus
01/17/2001CN1060803C Dealuminium Y molecular fixation glucose amylase and preparing method
01/16/2001US6175061 Production of polyhydroxyalkanoate in plants
01/16/2001US6175060 Transgenic plant having a cell transformed by a vector including dna which activates transcription of a structural gene under conditions of phosphate-starvation; recombinant production of proteins; disease resistance
01/16/2001US6175058 Nucleotide sequence having maize-preferred codons; for transformed plants allowing efficient site-directed recombination
01/16/2001US6175003 Nucleic acids encoding ribonucleases and methods of making them
01/16/2001US6174993 Short peptides which selectively modulate the activity of serine/threonine kinases
01/16/2001US6174716 Expression system which produces a polypeptide of defined amino acid sequence in a compatible host cell; from adaptor protein which regulates phosphatidylinositol 3-kinase activity; antiinflammatory/antiarthritic agents; diagnosis
01/16/2001US6174715 Polynucleotide coding for micrococcus polypeptide of defined amino acid sequence; for recombinant production; chemical intermediates for vitamin k and ubiquinones
01/16/2001US6174714 Lyss
01/16/2001US6174713 Candida cytoplasmic tryptophanyl-tRNA synthetase proteins, nucleic acids and strains comprising same
01/16/2001US6174706 Purified and isolated nucleic acid molecule having a nucleotide sequence encoding the triol polyketide synthase of aspergillus terreus
01/16/2001US6174703 Nucleotide sequences coding a polymerase binding protein; for the treatment of cancer, acquired immune deficiency syndrome, aging and cell proliferative defects
01/16/2001US6174700 Purification of a polypeptide compound having a polysaccharide binding domain by affinity phase separation
01/16/2001US6174694 Phosphorylation of serine containing substrate; incubate substrate with adenosine triphosphate and a enzymatic protein, monitor the amount of phosphorylation
01/16/2001US6174684 CYP3A4 NFSE variant and methods of use therefore
01/16/2001US6174682 Thioredoxin family active site molecules and uses therefor
01/16/2001US6174676 Cytokine-stress- and oncoprotein-activated human protein kinase kinases
01/16/2001US6174674 Detecting nucleotide sequence adjustment; hybridizing centromeric probe to human sample, hybridizing second teleomeric probe to human sample, detecting centromeric and telomeric hybridization positioning
01/16/2001CA2200192C Amidino and guanidino substituted inhibitors of trypsin-like enzymes
01/11/2001WO2001002601A2 Cell-based assay systems for examining hcv ns3 protease activity
01/11/2001WO2001002593A2 Control of gene expression in eukaryotic cells
01/11/2001WO2001002592A2 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants
01/11/2001WO2001002591A1 Plants expressing δ6-desaturase genes and oils from these plants containing pufas and method for producing unsaturated fatty acids
01/11/2001WO2001002589A2 Methods, compositions and genetic sequences for modulating flowering in plants, and plants genetically modified to flower early and tardily
01/11/2001WO2001002586A1 Human alpha 1,2-mannosidase
01/11/2001WO2001002585A1 Gene encoding cyclic lipopeptide acylase and expression of the same
01/11/2001WO2001002584A1 Dna encoding sucrose pts enzyme ii
01/11/2001WO2001002583A2 Orynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins
01/11/2001WO2001002582A1 Dsp-3 dual-specificity phosphatase
01/11/2001WO2001002581A1 Dsp-3 dual-specificity phosphatase
01/11/2001WO2001002580A1 Vectors, cells and processes for pyrimidine deoxyribonucleosides production
01/11/2001WO2001002577A1 Pseudomonas aeruginosa antigens
01/11/2001WO2001002568A2 Human genes and gene expression products
01/11/2001WO2001002559A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
01/11/2001WO2001002552A2 Double transgenic animals as models for neurodegenerative disease
01/11/2001WO2001002547A1 Process for producing l-lysine
01/11/2001WO2001002544A1 Process for producing l-amino acid
01/11/2001WO2001002543A1 Process for producing l-amino acid
01/11/2001WO2001002542A1 Process for producing l-amino acid
01/11/2001WO2001002541A2 Compositions and methods for regulating abscisic acid-induced closure of plant stomata
01/11/2001WO2001002432A1 Sh3-containing protein, dna and uses thereof
01/11/2001WO2001002430A2 Arabidopsis thaliana cdc7 and cdc27 homologs
01/11/2001WO2001002424A2 Peptide boronic acid inhibitors of hepatitis c virus protease
01/11/2001WO2001002420A1 PURIFIED AND ISOLATED MAT II β SUBUNIT NUCLEIC ACIDS AND POLYPEPTIDES AND THERAPEUTIC AND SCREENING METHODS USING SAME
01/11/2001WO2001001762A1 Construction of rice tolerant to iron deficiency
01/11/2001WO2001001749A2 FVIIa ANTAGONISTS
01/11/2001WO2000061608A3 Low-molecular inhibitors of complement proteases
01/11/2001WO2000055302A3 Genetically modified plants having modulated brassinosteroid signaling
01/11/2001WO2000053169A8 Method of inhibiting a chaperone protein
01/11/2001DE19931847A1 Immobilisierte Lipase Immobilized lipase
01/11/2001DE19931834A1 Identifizierung und Überexpression einer DNA-Sequenz codierend für eine 2-Methyl-6-phytylhydrochinon-methyltransferase in Pflanzen Identification and over-expression of a DNA sequence coding for a 2-methyl-6-phytylhydrochinon-methyltransferase in plant
01/11/2001DE19929485A1 Lytisches Enzym Lytic enzyme